MOH
- Marketing authorisation holder: X4 PHARMS
- Status: likely_approved
🇦🇪 Xolremdi in United Arab Emirates
Xolremdi (MAVORIXAFOR) regulatory status in United Arab Emirates.
Marketing authorisation
Xolremdi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United Arab Emirates
Frequently asked questions
Is Xolremdi approved in United Arab Emirates?
Yes. MOH has authorised it.
Who is the marketing authorisation holder for Xolremdi in United Arab Emirates?
X4 PHARMS holds the UAE marketing authorisation.